Mukka Proteins Ltd (MUKKA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Mukka Proteins Ltd on NSE and BSE, with an AI summary of each filing.
MUKKA PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 07 Nov 2026, 5:30 am
Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve the unaudited financial results ....
Intimation · 07 Nov 2026, 5:30 am
Mukka Proteins Board Meeting Scheduled for 7th Nov'26 to Consider Q2 Results Mukka Proteins Limited has scheduled a Board of Directors meeting on 7th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI Insider Trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will remain closed until 48 hours following the declaration of the financial results for designated persons and their immediate relatives.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 07 Nov 2026, 5:30 am
Intimation of US FDA Registration.
Others (Uncategorized) · 27 Oct 2026, 11:16 pm
Mukka Proteins Secures US FDA Facility Registration Mukka Proteins Limited has received a Certificate of Registration from Registrar Corp, Virginia, USA, confirming the registration of its facility with the U.S. FDA under the Federal Food, Drug, and Cosmetic Act. The registration is valid from 1st Oct'26 through 31st Dec'27. This regulatory milestone supports the company's business operations and enables commercial engagement with customers and target markets requiring mandatory U.S. FDA facility registration.
Intimation of commencement of commercial production by overseas subsidiary.
Others (Uncategorized) · 09 Oct 2026, 9:23 pm
Mukka Proteins' Oman Subsidiary Commences Commercial Production of Fish Meal and Oil Mukka Proteins Limited announced that its overseas subsidiary, United Gulf Fishery Products LLC, commenced commercial production of fish meal, fish oil, and fish soluble paste on 9th Oct'26. The facility is located in the Al Juba industrial area, Wilayat of Mahoot, Sultanate of Oman. The move is expected to enhance the subsidiary's output, strengthen the Group's overall production capabilities, and expand the company's footprint across the Middle East market.
Intimation of giving corporate guarantee and security by the Company.
Others (Uncategorized) · 09 Oct 2026, 9:12 pm
Mukka Proteins Approves Corporate Guarantee and Security of Rs 73.58 Cr for Oman Subsidiary The Board of Directors of Mukka Proteins approved providing a corporate guarantee, Standby Letter of Credit (SBLC), and security via fixed deposits on 9th Oct'26. The financial support, valued up to Rs 735.83 mn (Rs 73.58 cr), will secure credit facilities availed by its subsidiary, United Gulf Fishery Products LLC, Oman, from HDFC Bank. The transaction is conducted at arm's length, creating a contingent liability for Mukka Proteins up to the availed facility amount, with full recovery rights against the subsidiary upon invocation.
Intimation of Credit Rating.
Others (Uncategorized) · 07 Oct 2026, 10:15 pm
CARE Ratings Revises Mukka Proteins' Outlook to Stable; Reaffirms Ratings CARE Ratings reaffirmed Mukka Proteins Limited’s bank facilities at CARE BBB-/CARE A3, revising the outlook to Stable from Negative on 7th Oct'26. The revision reflects strong Q1FY27 performance, where consolidated revenue jumped ~187% YoY to ₹490 crore, driven by a ~93% increase in realisations and ~49% volume growth with PBILDT margins above 9%. Liquidity is supported by ₹47 crore raised via equity warrants and an unexecuted order book of ₹500–550 crore, offset by high working capital intensity and raw material price volatility.
Intimation of receipt of USDA NOP - Inputs Attestation.
Others (Uncategorized) · 06 Oct 2026, 9:00 pm
Mukka Proteins Secures USDA NOP Attestation for Eco Sphere Organic Fertilizer Mukka Proteins Limited has received the USDA NOP – Inputs Attestation from ECOCERT S.A.S., France, certifying that its product "Eco Sphere Organic Fertilizer" is suitable for organic farming under specified program conditions. Valid from 5th Oct'26 through 31st Mar'28, the certification enables the company to expand marketability and acceptance across key international organic farming markets, including the United States. This milestone strengthens Mukka Proteins' sustainable, value-added portfolio and enhances its export growth potential within high-value organic agriculture segments.
Intimation of delay in acquisition of Aqua Marine.
Others (Uncategorized) · 30 Sept 2026, 6:06 pm
Mukka Proteins Delays 51% Stake Acquisition in Aqua Marine to Jan'27 Mukka Proteins Limited announced a delay in completing its strategic acquisition of a 51% stake in partnership firm Aqua Marine for up to Rs 15.00 cr via capital contribution. Originally scheduled for completion by 30th Sep'26 following the initial announcement on 12th Jun'26, the expected completion date has now been extended to 31st Jan'27 due to procedural issues. The company stated that necessary steps are underway to resolve the delays and finalize the acquisition in due course.
Intimation of schedule of Analyst/Institutional Investors meeting.
Intimation · 24 Sept 2026, 10:45 pm
Mukka Proteins Reschedules One-on-One Investor Meeting With Suraag Capital Mukka Proteins Limited has rescheduled its virtual one-on-one meeting with investor Suraag Capital. Originally planned for 28th Sep'26, the interactive session will now take place on 29th Sep'26. The company confirmed that no unpublished price-sensitive information will be shared during the rescheduled interaction, and its latest investor presentation remains accessible on the corporate website.
Intimation of schedule of analyst/institutional investor meeting.
Intimation · 24 Sept 2026, 8:19 pm
Mukka Proteins Schedules One-on-One Investor Interaction with Suraag Capital Mukka Proteins Limited informed exchanges that it will participate in a one-on-one virtual meeting with Suraag Capital on 28th Sep'26, pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. The company stated that no unpublished price-sensitive information will be shared during the interaction. The latest investor presentation remains accessible on the company's website.
Intimation of the schedule of Analyst/Investor meeting.
Intimation · 23 Sept 2026, 1:54 am
Mukka Proteins Schedules Virtual Investor Meeting with International Finance Corporation Mukka Proteins Limited announced it will participate in a one-on-one virtual investor meeting with the International Finance Corporation (IFC) on 25th Sep'26. The company confirmed that no unpublished price-sensitive information will be shared during the interaction, and its latest investor presentation remains accessible via its official website.
Intimation of Schedule of Analyst/Investor Meet.
Intimation · 12 Sept 2026, 8:41 pm
Mukka Proteins Schedules Virtual Investor Meeting with ADD Capital Mukka Proteins Limited has confirmed its participation in a one-on-one institutional investor meeting with ADD Capital, scheduled virtually for 17th Sep'26. The engagement adheres to Regulation 30 of SEBI LODR Regulations, 2015. The company stated that no unpublished price-sensitive information (UPSI) will be shared during the interaction, and its latest investor presentation remains accessible via its official website.
Intimation of Voting Results and scrutinizer report of the 16th AGM held on Thursday, 10th September 2026.
Annual General Meeting · 12 Sept 2026, 6:56 pm
Intimation of outcome of 16th AGM.
Annual General Meeting · 11 Sept 2026, 4:14 am
Intimation of proceedings of 16th AGM.
Annual General Meeting · 11 Sept 2026, 4:08 am
Intimation regarding allotment of convertible warrants on preferential basis.
Others (Uncategorized) · 10 Sept 2026, 3:54 pm
Mukka Proteins Approves ₹47 Crore Convertible Warrants Allotment Mukka Proteins Limited approved the preferential allotment of 2.00 crore convertible warrants at an issue price of Rs. 23.50 per warrant, aggregating to Rs. 47.00 crore, to 15 non-promoter investors on 9th Sep'26. The allotment followed the receipt of a 25% upfront subscription amount of Rs. 5.88 per warrant. Each warrant is convertible into one fully paid-up equity share of face value Re. 1 upon payment of the remaining 75% within 18 months from the allotment date.
Intimation of receipt of EU - Inputs Attestation.
Others (Uncategorized) · 04 Sept 2026, 10:56 pm
Mukka Proteins Secures EU Inputs Attestation for Eco Sphere Organic Fertilizer Mukka Proteins has received an EU Inputs Attestation from ECOCERT S.A.S., France, confirming that its "Eco Sphere Organic Fertilizer" is certified for organic farming under EU Regulations 2018/848 and 2021/1165. The compliance certification is valid from 4th Sep'26 until 31st Mar'28. This approval enhances the product's marketability and international acceptance across European Union markets, directly advancing the company's strategic expansion into higher-margin, sustainable, and value-added organic agricultural inputs.
Intimation of acquisition of shares in Shipwaves Online Limited.
Others (Uncategorized) · 01 Sept 2026, 9:37 pm
Mukka Proteins To Acquire 16.77% Stake in Shipwaves Online On 01 Sep'26, Mukka Proteins' board approved a strategic investment of ₹13.19 Cr in Shipwaves Online Limited (SOL). The transaction involves acquiring 2,93,20,000 equity shares at ₹4.50 per share, resulting in a 16.77% post-acquisition stake. The deal, a related-party transaction at arm's length, aims to leverage synergies in logistics and SaaS solutions. For FY26, target entity SOL reported a turnover of ₹65.01 Cr and a PAT of ₹1.68 Cr. The acquisition is set to be completed by 31 Mar'27.
Intimation of press release.
Press Release · 01 Sept 2026, 3:53 pm
Intimation of receipt of in-principle approvals from NSE & BSE.
Others (Uncategorized) · 29 Aug 2026, 1:39 am
Mukka Proteins Receives Approval for Convertible Warrant Issuance Mukka Proteins has received in-principle approval from the NSE and BSE on 28 Aug'26 for a preferential issue of 200 million convertible warrants to non-promoters. The warrants, with a face value of Re. 1/-, will be issued at a price of Rs. 23.50/- each. Upon receipt of this approval, the company is permitted to proceed with the issue and allotment, which will convert into an equivalent number of equity shares. This action is subject to compliance with SEBI LODR and ICDR regulations.
Clarification w.r.t. intimations dated 12th August 2026 regarding investment in Swaccha Eco Solutions Private Limited.
Others (Uncategorized) · 20 Aug 2026, 9:27 pm
Mukka Proteins Corrects Investment Value in Swachha Eco Solutions Mukka Proteins has issued a clarification on 20-Aug'26 regarding its investment in Swachha Eco Solutions Private Limited (SESPL). The company corrected the total consideration for acquiring 26,500 equity shares at ₹250 per share to ₹66,25,000 from the previously miscalculated ₹64,92,500. This investment, part of a strategic plan to expand its Waste Management segment, will result in a 25.98% post-acquisition stake in SESPL. All other terms, including the number of shares and price per share, remain unchanged. The acquisition is expected by 31-Dec'26.
Intimation of dispatch of letter to shareholders whose e-mail addresses are not registered with the Company/Depositories.
Others (Uncategorized) · 18 Aug 2026, 9:49 pm
Mukka Proteins Announces FY26 AGM and Annual Report Access Mukka Proteins has scheduled its 16th Annual General Meeting (AGM) for 10th Sep'26 at 3:00 PM IST, to be held via video conferencing. The company is dispatching physical letters with a weblink to its FY 2025-26 Annual Report and AGM notice to shareholders whose email addresses are not registered. Electronic copies were sent to registered emails based on records as of 14th Aug'26. The company urges shareholders to update their KYC details with the registrar, Cameo Corporate Services.
Annual Report for the Financial Year 2025-26
Others (Uncategorized) · 18 Aug 2026, 9:34 pm
Notice of 16th Annual General Meeting to be held on Thursday, 10th September 2026.
Annual General Meeting · 18 Aug 2026, 9:21 pm